Mitigation of Late Renal and Pulmonary Injury After Hematopoietic Stem Cell Transplantation

Captopril therapy produces no detectable adverse effects when given after TBI. Captopril therapy reduces overall and pulmonary-related mortality after radiation-based HSCT, and there is a trend toward mitigation of chronic renal failure.